Bio-Connect

ELISA Kit for Glypican 3 (GPC3)

SEA971HU
Cloud-Clone Corp.
Product group Assays
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Cloud-Clone Corp.
  • Product Name
    ELISA Kit for Glypican 3 (GPC3)
  • Delivery Days Customer
    12
  • Assay Detection Range
    0.156-10ng/mL
  • Assay Precision
    Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Glypican 3 (GPC3) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high ...
  • Assay Sensitivity
    The minimum detectable dose of this kit is typically less than 0.062ng/mL
  • Assay Test Principle
    The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Glypican 3 (GPC3). Standards or samples are then added to the appropriate microtiter ...
  • Assay Time
    3h
  • Certification
    Research Use Only
  • UNSPSC
    41116158

References

  • Alyoussef A, Al-Gayyar MMH. Cytotoxic and partial hepatoprotective activity of sodium ascorbate against hepatocellular carcinoma through inhibition of sulfatase-2 in vivo and in vitro. Biomed Pharmacother. 2018,103:362-372. doi: 10.1016/j.biopha.2018.04.060
    Read this paper
  • Zhou F, Shang W, Yu X, et al. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment. Med Res Rev. 2018,38(2):741-767. doi: 10.1002/med.21455
    Read this paper
  • Zaghloul RA, El-Shishtawy MM, El Galil KH, et al. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma. Eur J Pharmacol. 2015,746:353-62. doi: 10.1016/j.ejphar.2014.11.008
    Read this paper
  • Abd El Gawad IA, Mossallam GI, Radwan NH, et al. Comparing prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins glypican-3, Alpha feto protein and carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients. J Egypt Natl Canc Inst. 2014,26(2):79-85. doi: 10.1016/j.jnci.2014.01.001
    Read this paper
  • Abdelgawad IA, Mossallam GI, Radwan NH, et al. Can Glypican3 be diagnostic for early hepatocellular carcinoma among Egyptian patients? Asian Pac J Cancer Prev. 2013,14(12):7345-9.
    Read this paper
  • Liu XF, Hu ZD, Liu XC, et al. Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: a systematic review and meta-analysis. Clin Biochem. 2014,47(3):196-200. doi: 10.1016/j.clinbiochem.2013.12.007
    Read this paper